Helena Bellini

Dr. Helena Bellini

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
PDF file
LRLais Razza
Lais Razza
LSLeonardo Afonso dos Santos
Leonardo Afonso dos Santos
LBLucas Borrione
Lucas Borrione
HBHelena Bellini
Helena Bellini
LBLuis C. Branco
Luis C. Branco
ABAndre R. Brunoni
Andre R. Brunoni
Electrical and magnetic brain stimulation techniques present distinct mechanisms and efficacy in the acute treatment of depression. This was an umbrella review of meta-analyses of randomized controlled trials of brain stimulation techniques for managing acute major depressive episodes. A systematic review was performed in the PubMed/MEDLINE databases from inception until March 2020. We included the English language meta-analysis with the most randomized controlled trials on the effects of any brain stimulation technique vs. control in adults with an acute depressive episode. Continuous and dichotomous outcomes were assessed. A Measurement Tool to Assess Systematic Reviews-2 was applied and the credibility of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation framework. Seven meta-analyses were included (5,615 patients), providing evidence for different modalities of brain stimulation techniques. Three meta-analyses were evaluated as having high methodological quality, three as moderate, and one as low. The highest quality of evidence was found for high frequency-repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation, and bilateral rTMS. There is strong clinical research evidence to guide future clinical use of some techniques. Our results confirm the heterogeneity of the effects across these techniques, indicating that different mechanisms of action lead to different efficacy profiles.

1 January 2020 in Clinics
Verified
Journal Article
Open access
HBHelena Bellini
Helena Bellini
ECEric Cretaz
Eric Cretaz
LRLuiz Felipe Rigonatti
Luiz Felipe Rigonatti
CCCarla Dominique Rodrigues De Conto
Carla Dominique Rodrigues De Conto
DMDébora Luciana Melzer-Ribeiro
Débora Luciana Melzer-Ribeiro
JGJose Gallucci-Neto
Jose Gallucci-Neto

30 July 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
HBHelena Bellini
Helena Bellini
ECEric Cretaz
Eric Cretaz
ACADRIANA Munhoz Carneiro
ADRIANA Munhoz Carneiro
PSPedro Henrique Rodrigues Da Silva
Pedro Henrique Rodrigues Da Silva
LSLeonardo Afonso dos Santos
Leonardo Afonso dos Santos
ABAndre R. Brunoni
Andre R. Brunoni
Treatment-resistant depression (TRD), characterized by the failure to achieve symptomatic remission despite multiple pharmacotherapeutic treatments, poses a significant challenge for clinicians. Electroconvulsive therapy (ECT) is an effective but limited option due to its cognitive side effects. In this context, magnetic seizure therapy (MST) has emerged as a promising alternative, offering comparable antidepressant efficacy with better cognitive outcomes. However, the clinical outcomes and cognitive effects of MST require further investigation. This double-blinded, randomized, non-inferiority study aims to compare the efficacy, tolerability, cognitive adverse effects, and neurophysiological biomarkers of MST with bilateral ECT (BT ECT) in patients with TRD. This study will employ multimodal nuclear magnetic resonance imaging (MRI) and serum neurotrophic markers to gain insight into the neurobiological basis of seizure therapy. Additionally, neurophysiological biomarkers will be evaluated as secondary outcomes to predict the antidepressant and cognitive effects of both techniques. The study design, recruitment methods, ethical considerations, eligibility criteria, interventions, and blinding procedures are described. The expected outcomes will advance the field by offering a potential alternative to ECT with improved cognitive outcomes and a better understanding of the underlying pathophysiology of depression and antidepressant therapies.

1 January 2025 in Brazilian Journal of Psychiatry
Verified
Journal Article
Open access
LALeonardo Afonso-Dos-Santos
Leonardo Afonso-Dos-Santos
ECEric Cretaz
Eric Cretaz
HBHelena Bellini
Helena Bellini
ACADRIANA Munhoz Carneiro
ADRIANA Munhoz Carneiro
JGJose Gallucci-Neto
Jose Gallucci-Neto
ABAndre R. Brunoni
Andre R. Brunoni
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)

21 May 2025
Verified
Book Chapter
Closed access
PDF file
HBHelena Bellini
Helena Bellini
ABAndré Russowsky Brunoni
André Russowsky Brunoni